Brief: Turk Ilac Signs Framework Agreement For Production And Sale Of AVIFAVIR Drug Used In Covid-19 Treatment
June 21 (Reuters) - TURK ILAC VE SERUM SANAYI AS TRILC.IS :
* SIGNS FRAMEWORK AGREEMENT WITH RUSSIA BASED CHROMIS LLC FOR PRODUCTION AND
SALE
OF AVIFAVIR DRUG USED IN COVID-19 TREATMENT
Source text for Eikon: ID:nIKA1w3G13
Further company coverage: TRILC.IS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Turk Ilac ve Serum Sanayi AS
See all newsTurk Ilac slides after debt restructuring entry
Turk Ilac says it granted 3-month interim protection for restructuring process
Brief: Turk Ilac Says It Signs $5.0 Mln Contract With Turkmenistan Health Ministry
Brief: Turk Ilac Says It Wins Turkish State Supply Office Tender Valued 209.6 Mln Lira + VAT
Brief: Turk Ilac Says It Signs Distribution Agreement With Aversi LLC